Improving access to HIV prevention and contraception for young women in Kenya
Exploring synergies in pharmacy-based delivery of PrEP and contraception for adolescent girls and young women in Kenya
This study is looking at how pharmacies can help young women in Kenya get better access to HIV prevention methods, like PrEP and contraception, by using nurse-navigators to make it easier for them to receive these important health services.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10919083 on NIH RePORTER |
What this research studies
This research investigates how pharmacy-based services can better deliver HIV prevention methods, specifically pre-exposure prophylaxis (PrEP), alongside contraception to adolescent girls and young women in Kenya. By utilizing nurse-navigators in retail pharmacies, the study aims to enhance the accessibility and uptake of these critical health services. The project will involve a cluster randomized clinical trial at 20 pharmacies in Kisumu, where participants will receive both daily oral PrEP and the dapivirine vaginal ring. The goal is to address the high rates of HIV and unintended pregnancies among this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women aged 15-24 in Kenya who are seeking contraception and are at risk for HIV.
Not a fit: Patients who are outside the age range of 15-24 or those who are not seeking contraception or HIV prevention methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the sexual and reproductive health outcomes for young women by providing easier access to essential HIV prevention and contraceptive services.
How similar studies have performed: Previous research has shown success in integrating pharmacy-based services for health interventions, making this approach promising yet still relatively novel in the context of PrEP and contraception for young women.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Harrington, Elizabeth K — University of Washington
- Study coordinator: Harrington, Elizabeth K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.